6 Results for "

Senegalia catechu (L. f.) P. J. H. Hurter & Mabb.

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Senegalia catechu (L. f.) P. J. H. Hurter & Mabb." in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-100809
CAS No.: 6027-91-4
Purity:  99.73%
Guvacine hydrochloride is an alkaloid from the nut of Areca catechu, acts as an inhibitor of GABA transporter, and dispalys modest selectivity for cloned GABA transporters with IC50s of 14 μM (human GAT-1), 39 μM (rat GAT-1), 58 μM (rat GAT-2), 119 μM (human GAT-3), 378 μM (rat GAT-3), and 1870 μM (human BGT-3).
1
1 Cited Publications
Cat. No.: HY-N2482A
CAS No.: 6027-92-5
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Guvacine hydrobromide, an alkaloid found in the nut of Areca catechu, is a potent GABA uptakp inhibitor. Guvacine hydrobromide inhibits rat GAT-1, rat GAT-2 and rat GAT-3 with IC50 values of 39 μM, 58 μM and 378 μM, respectively .
Cat. No.: HY-N2482
CAS No.: 498-96-4
Guvacine, an alkaloid found in the nut of Areca catechu, is a potent GABA uptakp inhibitor. Guvacine inhibits rat GAT-1, rat GAT-2 and rat GAT-3 with IC50 values of 39 μM, 58 μM and 378 μM, respectively .
Cat. No.: HY-N2655
CAS No.: 105330-59-4
5,7,4'-Tri-O-methylcatechin is a Flavonoids product that can be isolated from the wood of Acacia catechu (L.F.) Willd. .
Cat. No.: HY-N19050
Category:  

Extract

Target:  

Bacterial

Acacia catechu extract is rich in bioactive components such as catechins, tannins, and flavonoids, and has astringent, anti-inflammatory, antioxidant, and antibacterial properties.
Cat. No.: HY-L070
1,783 compounds

Neurodegenerative diseases are characterised by progressive dysfunction and death of neurons, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). Neuroprotection is an approach to preserve neurons so that neurons cannot be hurt by different pathological factors in neurodegenerative diseases. Neuroprotectors are some agonists and antagonists targeting some key targets in neuroprotactive signal pathways, such as calcium and sodium channel blockers, GABA receptor agonists, NMDA receptor Antagonists, etc. Current neuroprotectors cannot reverse existing damage, but they may protect against further nerve damage and slow down any degeneration of the central nervous system (CNS) and still play important roles in the treatment of neurodegenerative diseases.

MCE offers a unique collection of 1,783 compounds with potential neuroprotective activities. These compounds mainly act on some key targets in neuroprotetive signal pathways, such as calcium channel, sodium channel, adenosine A1 receptor, etc. MCE Neuroprotective Compopund Library is a useful tool in neuroprotective drug discovery.